A murine macrophage–like cell line, J774, acquired, in response to LPS, an ability to kill tumor necrosis factor (TNF)–insensitive target P815 mastocytoma cells, whereas another cell line, P388D1, did not. LPS–triggered signaling mechanisms between the two cell lines were compared with an aim to inquire about the possible nature of the above-mentioned difference. The results showed that two cell lines respond to LPS–treatment by parallel activation of both phospholipases C and A2 (PLC and PLA2) to approximately the same extent. The maximum response of both enzymes of J774 cells was noted within 10 min of the treatment, whereas that of P388D1 cells required more than 20 min. The other properties of LPS-responsive enzymes studied were similar between two cell lines, including Ca2+ augmentation of enzyme activation, participation of guanine nucleotide binding (G) proteins in the initial activation processes, and inhibition of enzyme activation by the prior treatment of cells with cholera or pertussis toxins etc. Moreover, LPS–triggered activation of PLC and PLA2 was found to be followed by the increase of PKC activities in both cell lines. In spite of these similarities, J774 cells possessed both basic and acidic forms of PKC activities, while P 388D1 cells owned only PKC of basic form. Nevertheless, the question why J774 cells, but not P388D1 cells, can acquire the tumoricidal activity, aganist P815 cells following LPS–treatment remains to be answered.